Partnership Opportunities
iPierian plans to develop partnerships with pharmaceutical companies to further expand into larger disease areas, including cardiovascular and metabolic diseases.
For inquiries related to our business please contact: BusinessDevelopment@ipierian.com
Current Collaborations
 | Johns Hopkins Medicine iPierian is collaborating with Dr. Jeffrey Rothstein of the Johns Hopkins University School of Medicine on $3.7 Million NIH Grand Opportunities Grant in the area of amyotrophic lateral sclerosis (ALS). |
 | University of CologneiPierian is collaborating with Dr. Brunhilde Wirth of the Institute of Human Genetics at the University of Cologne in order to build cell-based drug discovery models for spinal muscular atrophy (SMA). |
 | Gladstone Institute iPierian has a collaboration with The Gladstone Institute of Cardiovascular Disease and Dr. Deepak Srivastava, the institute’s director, in the area of calcific aortic valve disease (CAVD). |